Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor

By Kallas A.   Pooga M.   Benhida A.   Jacquemin M.   Saint-Remy J.-M.  

Thrombosis Research, Vol. 107, Iss. 6, 2002-09 ,pp. : 291-302

Elsevier

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura and Anti-Thrombotic Therapy Targeted to Von Willebrand Factor

By  

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-11 ,pp. : 762-766

Bentham Science Publishers

Access to resources Recommend Favorite

A novel method for quantitation of human von Willebrand factor messenger RNA

By Kerr R.   Stirling D.   Rae M.   White A.R.   Ludlam C.A.  

Thrombosis Research, Vol. 106, Iss. 4, 2002-05 ,pp. : 237-241

Elsevier

Access to resources Recommend Favorite

Domain Specific Monoclonal Anti-factor VIII Antibodies Generated by Inclusion Body-renatured Factor VIII Peptides

By Huang C.-C.   Li L.-T.   Shen M.-C.   Chen  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 405-415

Elsevier

Access to resources Recommend Favorite

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

By Castaman G.   Novella E.   Castiglia E.   Eikenboom J.C.J.   Rodeghiero F.  

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 135-138

Elsevier

Access to resources Recommend Favorite